---
title: "Spironolactone - Ascites"
sidebar: mydoc_sidebar
permalink: db00421-mesh-d001201-1.html
toc: false 
---


Path ID: `DB00421_MESH_D001201_1`
{% include image.html url="images/db00421-mesh-d001201-1.png" file="db00421-mesh-d001201-1.png" alt="db00421-mesh-d001201-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:D013148 | spironolactone | Drug |
| UniProt:P08235 | Mineralocorticoid receptor | Protein |
| MESH:D000450 | aldosterone | ChemicalSubstance |
| GO:0070294 | renal sodium ion absorption | BiologicalProcess |
| GO:0003092 | renal water retention | BiologicalProcess |
| MESH:D001201 | Ascites | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Spironolactone | NEGATIVELY REGULATES | Mineralocorticoid Receptor |
| Mineralocorticoid Receptor | POSITIVELY CORRELATED WITH | Aldosterone |
| Aldosterone | CONTRIBUTES TO | Renal Sodium Ion Absorption |
| Renal Sodium Ion Absorption | POSITIVELY CORRELATED WITH | Renal Water Retention |
| Renal Water Retention | CONTRIBUTES TO | Ascites |
|---------|-----------|---------|

Reference: [https://go.drugbank.com/drugs/DB00421#mechanism-of-action](https://go.drugbank.com/drugs/DB00421#mechanism-of-action){:target="_blank"}